Tag: schizophrenia
The Neuroscience Report—Vol. 10 (July 6, 2015): Schizophrenia
Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. Volume 10 (July 6, 2015): SCHIZOPHRENIA Journal Articles Treatment of Obesity […]
Letter to the Editor: Comparing Injection Site Pain with Paliperidone Palmitate Versus First-generation Depot Antipsychotics in Subjects with Schizophrenia
Dear Editor: Atypical long-acting injectable (LAI) antipsychotics may improve treatment options for patients with serious mental illnesses, such as schizophrenia and bipolar disorder.[1] A systematic review of 1,700 outpatients from 10 different studies reported a 30-percent decrease in the relative risk for relapse with LAIs versus oral antipsychotic medications.[2] However, first-generation depot medications, such as […]
Anosognosia in Schizophrenia: Hidden in Plain Sight
by Douglas S. Lehrer, MD, and Jennifer Lorenz, MD Dr. Lehrer is from Wright State University Boonshoft School of Medicine, Department of Psychiatry, Dayton, Ohio, and Summit Behavioral Healthcare, Cincinnati, Ohio; Dr. Lorenz is from Wright State University Boonshoft School of Medicine, Department of Psychiatry, Dayton, Ohio, and USAF Medical Center, Wright-Patterson Air Force Base, […]
Letter to the Editor: A case of Paranoid Schizophrenia and severe antipsychotic-induced Parkinson’s Disorder treated with a combination of olanzapine and lurasidone
Oleg V. Tcheremissine, MD, and Danielle Englert, MD Dr. Tcheremissine is Research Director, Department of Psychiatry and Behavioral Sciences, Carolinas Healthcare System; Dr. Englert is Director of Deep Brain Stimulation Program Center for Parkinson’s Disease and Movement Disorders, Department of Neurology Carolinas Healthcare System, Charlotte, North Carolina. Innov Clin Neurosci. 2013;10(9–10):10–14
Treatment of Obesity and Disability in Schizophrenia
by Martin Strassnig, MD, and Philip D. Harvey, PhD Dr. Harvey is Professor and Chief of Psychology and Dr. Strassnig is Assistant Professor and Director of ECT Services—Both with the Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida. Innov Clin Neurosci. 2013;10(7–8):15–19
Letter to the Editor: Minkowski Revisited: Glancing at the Clinical Core of Schizophrenic Vulnerability
by Yuichiro Abe, MD, PhD; and Andrea Raballo, MD, PhD Dr. Abe is from Department of Psychophysiology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan; and Dr. Raballo is from Department of Mental Health, Azienda Unitá Sanitaria Locale di Reggio Emilia, Reggio Emilia, Italy. Innov Clin Neurosci. 2013;10(3):10–11
Hematologic Impact of Antibiotic Administration on Patients Taking Clozapine
by Michael Shuman, PharmD; Tammie Lee Demler, PharmD, MBA, BCPP; Eileen Trigoboff, RN, DNS; and Lewis A. Opler, MD, PhD Dr. Shuman is from the Department of Pharmacy, Buffalo Psychiatric Center, Buffalo, New York; Drs. Demler and Trigoboff are from Buffalo Psychiatric Center in Buffalo, New York, and with the State University of New York […]
Technology, Society, and Mental Illness: Challenges and Opportunities for Assessment and Treatment
by Philip D. Harvey, PhD, and Richard SE Keefe, PhD Dr. Harvey is from the University of Miami School of Medicine, Miami, Florida; Dr. Keefe is Professor of Psychiatry and Behavioral Sciences at Duke University Medical Center, Durham, North Carolina. Innov Clin Neurosci. 2012;9(11–12):47–50
An OCD Patient Presenting with a Cerebellum Venous Variant in a Family with a Strong Schizophrenia Loading: A Case Report
by Miguel Palma, MD; Nuno Borja-Santos, MD; Bruno Trancas, MD; Catarina Klut, MD; and Graça Cardoso, MD, PhD Drs. Palma, Borja-Santos, Trancas, and Klut are from Hospital Professor Doutor Fernando Fonseca, EPE, Amadora, Portugal; and Dr. Cardoso is from Faculdade de Ciências Médicas, FCM, Universidade Nova de Lisboa, Lisboa, Portugal. Innov Clin Neurosci. 2012;9(9):18–20
